This company has been marked as potentially delisted and may not be actively trading. Lianluo Smart (LLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LLIT vs. CATX, INFU, NSPR, TMDIF, PETV, HSAQ, RVP, GBS, CTCX, and BTCYShould you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include Perspective Therapeutics (CATX), InfuSystem (INFU), InspireMD (NSPR), Titan Medical (TMDIF), PetVivo (PETV), Health Sciences Acquisitions Co. 2 (HSAQ), Retractable Technologies (RVP), GBS (GBS), Carmell (CTCX), and Biotricity (BTCY). These companies are all part of the "medical" sector. Lianluo Smart vs. Its Competitors Perspective Therapeutics InfuSystem InspireMD Titan Medical PetVivo Health Sciences Acquisitions Co. 2 Retractable Technologies GBS Carmell Biotricity Lianluo Smart (NASDAQ:LLIT) and Perspective Therapeutics (NYSEAMERICAN:CATX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation. Do institutionals & insiders have more ownership in LLIT or CATX? 28.8% of Lianluo Smart shares are owned by institutional investors. Comparatively, 54.7% of Perspective Therapeutics shares are owned by institutional investors. 22.9% of Lianluo Smart shares are owned by company insiders. Comparatively, 3.7% of Perspective Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer LLIT or CATX? In the previous week, Perspective Therapeutics had 4 more articles in the media than Lianluo Smart. MarketBeat recorded 4 mentions for Perspective Therapeutics and 0 mentions for Lianluo Smart. Lianluo Smart's average media sentiment score of 0.00 equaled Perspective Therapeutics'average media sentiment score. Company Overall Sentiment Lianluo Smart Neutral Perspective Therapeutics Neutral Is LLIT or CATX more profitable? Lianluo Smart has a net margin of 0.00% compared to Perspective Therapeutics' net margin of -7,688.50%. Lianluo Smart's return on equity of 0.00% beat Perspective Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Lianluo SmartN/A N/A N/A Perspective Therapeutics -7,688.50%-33.37%-28.44% Which has more volatility & risk, LLIT or CATX? Lianluo Smart has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500. Comparatively, Perspective Therapeutics has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Which has preferable earnings and valuation, LLIT or CATX? Lianluo Smart has higher earnings, but lower revenue than Perspective Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianluo Smart$380K268.75-$4.45MN/AN/APerspective Therapeutics$1.45M248.90-$79.28MN/AN/A Do analysts recommend LLIT or CATX? Perspective Therapeutics has a consensus target price of $12.70, suggesting a potential upside of 161.32%. Given Perspective Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Perspective Therapeutics is more favorable than Lianluo Smart.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lianluo Smart 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Perspective Therapeutics 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 3 Strong Buy rating(s) 3.17 SummaryPerspective Therapeutics beats Lianluo Smart on 8 of the 14 factors compared between the two stocks. Get Lianluo Smart News Delivered to You Automatically Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LLIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLIT vs. The Competition Export to ExcelMetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$102.13M$75.10M$6.03B$10.28BDividend YieldN/AN/A5.68%4.75%P/E RatioN/A9.8686.0326.56Price / Sales268.7540.03615.64229.69Price / CashN/A18.4137.2660.57Price / Book-78.2917.1212.756.52Net Income-$4.45M-$27.88M$3.31B$276.43M Lianluo Smart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLITLianluo SmartN/A$46.19-5.7%N/A+6,428.6%$102.13M$380K0.006CATXPerspective TherapeuticsN/A$3.43flat$12.56+266.1%N/A$254.72MN/A0.0070Analyst ForecastGap UpINFUInfuSystem4.4953 of 5 stars$10.27-0.9%$13.50+31.5%+33.4%$209.78M$139.89M171.20410NSPRInspireMD2.8615 of 5 stars$2.40-0.4%$4.50+87.5%-10.1%$100.13M$7.07M-3.2050TMDIFTitan MedicalN/A$0.44-1.4%N/A+1,151.8%$50.60M$17.63M-0.3550Gap DownPETVPetVivoN/A$1.19+8.2%N/A+128.6%$34.80M$1.05M-2.6420News CoverageGap DownHigh Trading VolumeHSAQHealth Sciences Acquisitions Co. 2N/A$2.48+0.8%N/A-34.5%$27.81MN/A0.004RVPRetractable Technologies1.9805 of 5 stars$0.84-0.4%N/A+28.4%$25.12M$38.16M-1.55240News CoveragePositive NewsGBSGBSN/A$1.02-10.5%N/A-27.2%$15.19MN/A-1.827News CoverageCTCXCarmellN/A$0.71-4.1%N/A+73.2%$14.84M$32.84K0.0014BTCYBiotricityN/A$0.52-2.8%N/A+136.3%$13.77M$12.06M-0.4840Gap Up Related Companies and Tools Related Companies Perspective Therapeutics Competitors InfuSystem Competitors InspireMD Competitors Titan Medical Competitors PetVivo Competitors Health Sciences Acquisitions Co. 2 Competitors Retractable Technologies Competitors GBS Competitors Carmell Competitors Biotricity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LLIT) was last updated on 10/12/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWarren Buffett’s #1 AI Stock is Not Even on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lianluo Smart Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lianluo Smart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
